Gender and life course in multiple sclerosis
People with multiple sclerosis (MS) experience differences in disease progression, treatment response and life course based on sex and gender. Our project aims to improve personalised, sex- and gender-sensitive MS care and ensure better support.
Project description
MS affects more women than men. Yet many aspects of how sex and gender influence patients’ life course, lived experience and disease trajectory remain unclear. Our project aims to systematically examine biological and gender differences in people with MS. By analysing data from the Swiss Multiple Sclerosis Registry (SMSR), we aim to understand how interactions between MS disease course and sex and gender shape social status, healthcare access, health outcomes and daily living with MS.
Research aim
Our goal is to make MS care more sex- and gender-sensitive and inclusive. We will identify the practical challenges that men and women with MS face – whether in symptom management, treatment access, or social support. By recognising these differences, we can help ensure that all MS patients receive the care and support they need. Our project will provide practical insight that improves healthcare decisions, enhances patient well-being and supports a more equitable healthcare system.
Purpose
For people living with MS, personalised support greatly improves their quality of life. Understanding how gender shapes disease experiences will help improve treatment strategies, healthcare policies and patient support. Our collaboration with the Swiss MS Society and neurologists ensures that research findings will reach those who need them most – people with MS, their families and healthcare providers. Our work will also help create a more responsive sex- and gender-adapted healthcare system.
Original title
Gender & Life Course in Multiple Sclerosis (GeLiCo-MS): A gender-based life course perspective to improve health determinants and disease management